|
Çѱ¹ ÆÄ·º¼¿ |
[Çѱ¹ Parexel] Biostatistician ¸ðÁý
¼¿ï °³²±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
STAT/DM |
1³â¡è |
ä¿ë½Ã |
11.17 |
|
|
(ÁÖ)½ì¹ÙÀÌ¿ÀÅØ |
[µà¿À¶ô] ¾à±¹ ¹× º´ÀÇ¿ø ¿µ¾÷ °æ·Â(¼¿ï,¼öµµ±Ç)
¼¿ï ¼Ãʱ¸, °æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
08.21 |
|
|
¿ø¹ÙÀÌ¿ÀÁ¨ |
¿ø¹ÙÀÌ¿ÀÁ¨ Æ÷ÀåÀç µðÀÚÀÎ ¹× ȨÆäÀÌÁö °ü¸® µðÀÚÀÌ³Ê ¸ðÁý
°æºÏ ±¸¹Ì½Ã | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦Ç°/»ê¾÷µðÀÚÀÎ |
2³â¡è |
ä¿ë½Ã |
12.15 |
|
|
(ÁÖ)ÀÎÁ§Å¸ |
Ç°Áú°ü¸® QA, QC ä¿ë °ø°í
°æ±â ±ºÆ÷½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
2³â¡è |
ä¿ë½Ã |
09.06 |
|
|
Á¦ÀÌÄÉÀÌÁ¦¾à(ÁÖ) |
Á¦ÀÌÄÉÀÌÁ¦¾à(ÁÖ) ÇØ¿Ü¿µ¾÷ÆÀ Á÷¿ø ¸ðÁýÇÕ´Ï´Ù
°æ±â ¼º³²½Ã ¼öÁ¤±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
2³â¡è |
ä¿ë½Ã |
02.21 |
|
|
¸ÓÅ©(ÁÖ) |
Á¦Ç° °ü¸®ÀÚ N&I(HSL)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
03.18 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆÄ·º¼¿ ÄÚ¸®¾Æ Á¤±ÔÁ÷ CRA ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
12.08 |
|
|
(ÁÖ)Å´½ºÁ¦¾à |
Å´½ºÁ¦¾à µô·¯ ¹× ÇÁ¸®·£¼ ¸ðÁýÇÕ´Ï´Ù
Àü±¹ ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
»ó½Ãä¿ë |
01.02 |
|
|
¸ÓÅ©(ÁÖ) |
Product Manager-N&I (HSL) (3³â ³»¿Ü, PM Or Sales °æ·ÂÀÚ)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
03.19 |
|
|
(ÁÖ)º§¸óÆ®¸®½áÄ¡ |
(ÁÖ)º§¸óÆ®¸®½áÄ¡ ½ÅÀÔ / °æ·Â CRA ¸ðÁý
¼¿ï ¼ºµ¿±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.24 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆÄ·º¼¿ ÄÚ¸®¾Æ ÀǾàÇ° Regulatory Affairs °æ·ÂÁ÷ ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
11.17 |
|
|
(ÁÖ)Çѱ¹½´³ÚÁ¦¾à |
Çѱ¹½´³ÚÁ¦¾à ´ë°ü¾÷¹« ¹× ÀÎÇã°¡ ¾÷¹« °æ·ÂÀÚ ¸ðÁý
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
2³â¡è |
ä¿ë½Ã |
09.30 |
|
|
³ª³ë¸ÞµðÄ® |
ÀÇ·á±â±â,±â´É¼ºÈÀåÇ°
ºÎ»ê ºÎ»êÁø±¸ | ´ëÇÐ(2~3³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
01.09 |
|
|
(ÁÖ)¶õµ¶½ºÄÚ¸®¾Æ |
(ÁÖ)¶õµ¶½ºÄÚ¸®¾Æ [°æ·Â] Çмú ¹× ¿µ¾÷Áö¿ø-ü¿ÜÁø´ÜÀÇ·á±â
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
1³â¡è |
ä¿ë½Ã |
01.31 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ-CRA/Sr.CRA ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
02.14 |
|